¥48,500
biological source
human
Quality Segment
recombinant
expressed in E. coli
assay
>97% (SDS-PAGE)
form
lyophilized powder
potency
0.25-1.0 mg
mol wt
~8.2 kDa
packaging
pkg of 25 μg
storage condition
avoid repeated freeze/thaw cycles
technique(s)
cell culture | mammalian: suitable
impurities
endotoxin, tested
UniProt accession no.
storage temp.
−20°C
Gene Information
human ... CCL26(10344)
General description
Biochem/physiol Actions
Physical form
Analysis Note
1 of 1
当該品目 | |||
|---|---|---|---|
| assay >97% (SDS-PAGE) | assay ≥97% (SDS-PAGE and N-terminal analysis) | assay ≥97% (SDS-PAGE) | assay ≥98% (HPLC), ≥98% (SDS-PAGE) |
| technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable |
| biological source human | biological source human | biological source human | biological source human |
| recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in NSO cells | recombinant expressed in E. coli |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level - |
| form lyophilized powder | form lyophilized powder | form lyophilized powder | form lyophilized |
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Inhalation - Eye Irrit. 2
保管分類
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Substances Subject to be Indicated Names
ishl_indicated
Substances Subject to be Notified Names
ishl_notified
E8399-25UG-PW: + E8399-BULK: + E8399-25UG:4548173948881 + E8399-VAR:
jan




